NL NLI HOLDINGS, INC.
Industrial Inorganic Chemicals · NYSE · SEC CIK 72162 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.3%
TTM net income YoY-150.9%
TTM EPS YoY-150.0%
Revenue 3-yr CAGR1.6%
Net income 3-yr CAGR—
Margins
Gross margin32.5%
Operating margin9.8%
Net margin-3.0%
FCF margin5.8%
EBITDA margin11.9%
Returns
ROE-1.3%
ROA-1.0%
ROIC (approx.)4.8%
Asset turnover0.34x
Leverage & solvency
Liabilities / assets19.8%
Debt / equity0.00x
Current ratio7.25x
Interest coverage369.50x
Cash quality & payout
Operating cash flow / net income-2.69x
Accruals ratio-3.7%
Payout ratio—
Capex / revenue2.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $158.28M | $145.94M | $161.29M | $166.56M | $140.81M |
| Cost of revenue | $110.11M | $104.58M | $112.07M | $117.76M | $98.07M |
| Gross profit | $48.18M | $41.36M | $49.22M | $48.80M | $42.75M |
| R&D expense | $0 | $0 | $0 | $0 | $0 |
| SG&A expense | $25.57M | $24.34M | $23.78M | $23.36M | $22.22M |
| Operating income | $10.68M | $37.88M | $14.13M | $13.73M | $10.49M |
| Interest expense | $767,000 | $530,000 | $746,000 | $941,000 | $1.14M |
| Pretax income | -$51.42M | $83.32M | -$6.42M | $39.24M | $60.84M |
| Income tax | -$16.05M | $14.06M | -$7.00M | $2.79M | $7.48M |
| Net income | -$37.83M | $67.23M | -$2.31M | $33.84M | $51.19M |
| EBITDA | $14.33M | $41.57M | $18.10M | $17.71M | $14.33M |
| EPS (basic) | -0.77 | 1.38 | -0.05 | 0.69 | 1.05 |
| EPS (diluted) | -0.77 | 1.38 | -0.05 | 0.69 | 1.05 |
| Dividends declared per share | 0.57 | 0.75 | 0.28 | 0.63 | 0.24 |
| Weighted avg. shares (diluted) | 48.86M | 48.84M | 48.83M | 48.81M | 48.80M |
| Balance sheet | |||||
| Cash & equivalents | $110.61M | $163.15M | $111.52M | $68.87M | $147.00M |
| Short-term investments | — | — | $53.15M | $70.16M | — |
| Inventory | $30.41M | $28.37M | $30.71M | $31.29M | $25.64M |
| Current assets | $159.90M | $237.96M | $218.26M | $193.97M | $193.65M |
| PP&E, net | $23.71M | $24.03M | $25.86M | $28.69M | $29.18M |
| Goodwill | $27.16M | $27.16M | $27.16M | $27.16M | $27.16M |
| Total assets | $464.22M | $578.26M | $576.66M | $609.87M | $596.15M |
| Current liabilities | $20.58M | $91.06M | $30.45M | $32.05M | $30.60M |
| Total liabilities | $87.43M | $162.35M | $184.90M | $207.12M | $211.18M |
| Shareholders' equity | $358.77M | $396.90M | $369.81M | $382.15M | $362.47M |
| Shares outstanding | 48.86M | 48.85M | 48.83M | 48.82M | 48.82M |
| Cash flow statement | |||||
| Operating cash flow | -$36.40M | $25.57M | $37.00M | $26.93M | $17.61M |
| Capital expenditure | $3.75M | $1.43M | $1.13M | $3.69M | $4.09M |
| Free cash flow | -$40.15M | $24.14M | $35.87M | $23.24M | $13.52M |
| Investing cash flow | -$2.44M | $58.87M | $22.10M | -$67.87M | $6.71M |
| Financing cash flow | -$31.30M | -$41.63M | -$15.23M | -$36.80M | -$14.35M |
| Depreciation & amortization | $3.65M | $3.69M | $3.97M | $3.98M | $3.84M |
| Dividends paid | $17.60M | $15.60M | $13.70M | $13.70M | $11.70M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.